UK-based QinetiQ Group has received approval from the Foreign Investment Policy Division to acquire 45.92 million shares in pSivida as consideration for its 41.3% shareholding in UK operating subsidiary pSiMedica Ltd.
13/07/2004 - 22:00
pSivida Limited - 08-Jul-04
13/07/2004 - 22:00
